Amerisourcebergen (ABC) Osake Kurssi

AmerisourceBergen Corp primarily operates in the pharmaceutical distribution industry.

The main competitors of AmerisourceBergen Corp in the market include McKesson Corporation and Cardinal Health Inc. These companies are key players in the pharmaceutical distribution industry, providing similar services and products. AmerisourceBergen Corp competes with these rivals in terms of market share, customer relationships, and supply chain management. These competitors also operate on a global scale, catering to the needs of healthcare providers and pharmaceutical manufacturers. Overall, AmerisourceBergen faces strong competition from McKesson Corporation and Cardinal Health Inc in its efforts to maintain its position as a leading player in the pharmaceutical distribution market.

AmerisourceBergen Corp, founded in 2001, is a global healthcare solutions company based in the United States. It specializes in pharmaceutical sourcing and distribution services, serving both pharmaceutical manufacturers and healthcare providers. With its extensive network of distribution centers, AmerisourceBergen offers a wide range of products and services to support patient care and deliver vital medications. The company has a rich history of growth and innovation, expanding its operations globally and establishing itself as a leader in the healthcare industry. AmerisourceBergen continues to evolve and adapt to the changing needs of the healthcare landscape, striving to improve patient outcomes and advance the delivery of healthcare services.

AmerisourceBergen Corp, a leading global healthcare solutions company, has achieved several significant milestones. The company has consistently expanded its market reach through strategic acquisitions and partnerships, solidifying its position as a major player in the pharmaceutical distribution industry. AmerisourceBergen Corp has also demonstrated its commitment to innovation by adopting advanced technologies and enhancing its digital capabilities. Furthermore, the company's strong financial performance, consistent revenue growth, and successful execution of its business strategies have contributed to its continuous success and recognition as a Fortune 11 company. AmerisourceBergen Corp's dedication to serving the healthcare needs of patients and providing exceptional value to its customers have allowed it to become a trusted partner in the industry.

AmerisourceBergen Corp is primarily present in the United States, one of the largest pharmaceutical markets globally. With headquarters in Pennsylvania, the company operates in various regions across the US, including key cities like California, New York, Texas, and Florida. AmerisourceBergen provides pharmaceutical distribution and related services to a wide range of healthcare providers, including hospitals, pharmacies, and physician practices. With a strong presence across the American healthcare landscape, AmerisourceBergen Corp plays a vital role in ensuring the efficient and reliable distribution of pharmaceutical products throughout the United States.

AmerisourceBergen Corp represents a strong commitment to integrity, innovation, and collaboration. The company values client relationships and aims to provide superior service by fulfilling the healthcare needs of their customers. With a mission to improve patient access to pharmaceuticals and medical products, AmerisourceBergen Corp operates under the corporate philosophy that emphasizes reliable distribution networks, cutting-edge technology solutions, and industry expertise. By leveraging their extensive network, they work towards delivering exceptional value to healthcare providers and pharmaceutical manufacturers. AmerisourceBergen Corp strives to foster a culture of trust, integrity, and transparency, ensuring sustainable growth and success in the healthcare industry.

Analyytikot asettavat tällä hetkellä Amerisourcebergen-osakkeelle keskimääräisen tavoitehinnan 213,76 USD (mediaani: 213,18 USD), mikä merkitsee −30,8 % viimeisimpään hintaan verrattuna. Konsensus perustuu 21 analyytikkoarvioon.

Amerisourcebergen Analyytikkojen kursstavoitteet 2026

20 analyytikkoa arvioi tällä hetkellä Amerisourcebergen-osaketta: 13 suosittaa ostoa, 7 pitoa ja 0 myyntiä.

Amerisourcebergen Analyytikkojen kursstavoitteet 2026

Nykyisellä valuuttakurssilla Amerisourcebergen-osake noteerataan hintaan 275,71 EUR (309,05 USD).

Amerisourcebergen-osake (ABC) on listattuna 8 pörssissä, muun muassa: NYSE (ABC), London (0HF3.L), SIX (Zürich) (ABGCHF.SW), XETRA (ABG.DE), Frankfurt (ABG.F), München (ABG.MU), Düsseldorf (ABG.DU).

AmerisourceBergen Corp is an international company based in the USA that specializes in providing innovative solutions in the healthcare industry. The company offers a wide range of products and services that enable healthcare facilities to operate more efficiently and improve patient care. The business model of AmerisourceBergen Corp is based on three main business areas: 1. Pharmaceutical Distribution: The company is one of the largest pharmaceutical distributors in North America and offers a wide range of products and services to meet the demand for pharmaceuticals and medications. This includes specialty pharmaceuticals, biosimilars, and generics. 2. Outsourcing Services: AmerisourceBergen offers a variety of outsourcing services, including medication manufacturing, supply chain support, and consultation and training for healthcare professionals. 3. Value Assessment: Lastly, AmerisourceBergen provides value assessment services that enable customers to better understand and communicate the impact and benefits of their products. Together, these three business areas form the foundation of AmerisourceBergen's business model and enable the company to offer a variety of products and services to improve the quality of patient care and efficiency in the healthcare industry. One example of the products offered by AmerisourceBergen is oncology therapies. The company is a major provider of cancer medications in North America. It also works closely with insurance companies and other partners to ensure that cancer patients have access to necessary treatments and services. This product is an example of how AmerisourceBergen combines its core business areas to meet the demand for innovative solutions in healthcare. SEO-optimized terms found in this text include "pharmaceutical distributors," "outsourcing services," "value assessment services," and "oncology therapies." These terms are used to clarify the topic of the text and increase traffic to the AmerisourceBergen website by being found by search engines. By using such key terms, the text also strengthens the online visibility of AmerisourceBergen and contributes to improving the company's online marketing strategy.

Liikevaihtoa ei voida laskea Amerisourcebergen:lle tällä hetkellä.

Voittoa ei voida laskea Amerisourcebergen:lle tällä hetkellä.

P/E-suhdetta ei voida laskea Amerisourcebergen:lle tällä hetkellä.

P/S-suhdetta ei voida laskea Amerisourcebergen:lle tällä hetkellä.

Amerisourcebergen:n Eulpool-laatuscore on 5/10.

Amerisourcebergen:n ISIN on US03073E1055. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Amerisourcebergen:n WKN on 766149. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Amerisourcebergen:n ticker on ABC. Tämä pörssinoteeraus käytetään Amerisourcebergen-osakkeiden kauppaan pörssissä.